Awaiting product image

MSD NOBIVAC CANINE DAPPV + CV 25 x 1d

R1 600,63 excl.

A modified live vaccine for the immunisation of healthy dogs against canine distemper virus, adenovirus type 2, infectious canine hepatitis, parainfluenza, parvovirus, leptospirosis and corona virus.

Description

NOBIVAC® CANINE 1 -DAPPVL2 + CV

Reg. No. G3893 (Act 36/1947)

Namibia Reg. No. V07/24.1/902 [NS2]

This vaccine may only be used by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-veterinary Professions Act, 1982 (Act No. 19 of 1982).

INDICATIONS

A modified live vaccine for the immunisation of healthy dogs against canine distemper virus, adenovirus type 2, infectious canine hepatitis, parainfluenza, parvovirus, leptospirosis and corona virus.

COMPOSITION

Modified live vaccine containing canine distemper virus, adenovirus type 2, parainfluenza virus, parvovirus type 2b strain, killed feline enteric corona virus and inactivated Leptospira (L. canicola and L. icterohaemorrhagiae) bacterin.

Maximum moisture content at release: ≤ 5,5 %.

Contains gentamicin and thimerosal as preservative.

STORAGE INSTRUCTIONS

  • Store between 2 °C – 8 °C in a refrigerator.
  • Do not freeze.
  • Protect from light.
  • Use entire contents immediately after reconstitution.

WARNINGS

  • DO NOT VACCINATE PREGNANT BITCHES.
  • Vaccinate only healthy, non-parasitised dogs.
  • Do not mix Nobivac® Canine 1 -DAPPVL2 + CV with any other vaccine or medication.
  • Do not over- or underdose the vaccine.
  • Do not inject intravenously.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.